Terms: = Endocrine gland cancer AND PIM1, PIM, 5292, ENSG00000137193, P11309 AND Diagnosis
9 results:
1. AUM302, a novel triple kinase pim/PI3K/mTOR inhibitor, is a potent in vitro pancreatic cancer growth inhibitor.
Ingle K; LaComb JF; Graves LM; Baines AT; Bialkowska AB
PLoS One; 2023; 18(11):e0294065. PubMed ID: 37943821
[TBL] [Abstract] [Full Text] [Related]
2. Endoscopic versus Nonendoscopic Surgery for Resection of Craniopharyngiomas.
Abiri A; Roman KM; Latif K; Goshtasbi K; Torabi SJ; Lehrich BM; Mohyeldin A; Hsu FPK; Kuan EC
World Neurosurg; 2022 Nov; 167():e629-e638. PubMed ID: 36041722
[TBL] [Abstract] [Full Text] [Related]
3. pim Kinases and Their Relevance to the PI3K/AKT/mTOR Pathway in the Regulation of Ovarian cancer.
Aziz AUR; Farid S; Qin K; Wang H; Liu B
Biomolecules; 2018 Feb; 8(1):. PubMed ID: 29401696
[TBL] [Abstract] [Full Text] [Related]
4. pim-1 contributes to the malignancy of pancreatic cancer and displays diagnostic and prognostic value.
Xu J; Xiong G; Cao Z; Huang H; Wang T; You L; Zhou L; Zheng L; Hu Y; Zhang T; Zhao Y
J Exp Clin Cancer Res; 2016 Sep; 35(1):133. PubMed ID: 27596051
[TBL] [Abstract] [Full Text] [Related]
5. MicroRNA‑506 participates in pancreatic cancer pathogenesis by targeting pim3.
Du J; Zheng X; Cai S; Zhu Z; Tan J; Hu B; Huang Z; Jiao H
Mol Med Rep; 2015 Oct; 12(4):5121-6. PubMed ID: 26238203
[TBL] [Abstract] [Full Text] [Related]
6. MicroRNA-33a-mediated downregulation of pim-3 kinase expression renders human pancreatic cancer cells sensitivity to gemcitabine.
Liang C; Yu XJ; Guo XZ; Sun MH; Wang Z; Song Y; Ni QX; Li HY; Mukaida N; Li YY
Oncotarget; 2015 Jun; 6(16):14440-55. PubMed ID: 25971209
[TBL] [Abstract] [Full Text] [Related]
7. Performance of K-ras mutation analysis plus endoscopic ultrasound-guided fine-needle aspiration for differentiating diagnosis of pancreatic solid mass: a meta-analysis.
Xu Y; Hu D; Zhu Q; Sun Y
Chin Med J (Engl); 2014; 127(18):3296-301. PubMed ID: 25266530
[TBL] [Abstract] [Full Text] [Related]
8. Endoscopic ultrasound elastography for differentiating between pancreatic adenocarcinoma and inflammatory masses: a meta-analysis.
Li X; Xu W; Shi J; Lin Y; Zeng X
World J Gastroenterol; 2013 Oct; 19(37):6284-91. PubMed ID: 24115828
[TBL] [Abstract] [Full Text] [Related]
9. Calix[6]arene bypasses human pancreatic cancer aggressiveness: downregulation of receptor tyrosine kinases and induction of cell death by reticulum stress and autophagy.
Pelizzaro-Rocha KJ; de Jesus MB; Ruela-de-Sousa RR; Nakamura CV; Reis FS; de Fátima A; Ferreira-Halder CV
Biochim Biophys Acta; 2013 Dec; 1833(12):2856-2865. PubMed ID: 23872419
[TBL] [Abstract] [Full Text] [Related]
